| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2012 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNUM GROUP | 7 | Q2 2024 | 15.9% |
| THE CIGNA GROUP | 7 | Q2 2024 | 12.3% |
| MOLINA HEALTHCARE INC | 7 | Q2 2024 | 11.7% |
| DANAHER CORPORATION | 7 | Q2 2024 | 10.4% |
| ENOVIS CORPORATION | 6 | Q1 2024 | 9.8% |
| BAXTER INTL INC | 6 | Q2 2024 | 11.2% |
| QUANTERIX CORP | 6 | Q1 2024 | 4.9% |
| IDEAYA BIOSCIENCES INC | 5 | Q2 2024 | 4.9% |
| AMGEN INC | 4 | Q4 2023 | 9.0% |
| GLOBUS MED INC | 4 | Q2 2024 | 11.4% |
View BOONE CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View BOONE CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.